Yahoo Web Search

Search results

  1. 18 hours ago · Silo Pharma shares surge due to a global license agreement for Alzheimer's drug SPC-14, aiming to utilize the FDA's 505(b)(2) pathway. SPC-14 shows promise in stress reduction and cognitive ...

  2. 5 hours ago · Silo stock had closed at $1.07, up 5.9 percent on Monday. It has traded in the range of $0.84 - $3.05 in the last 1 year. The views and opinions expressed herein are the views and opinions of the ...

  3. 18 hours ago · Silo Pharma recently announced a similar exclusive license agreement for its lead drug candidate, SPC-15, an intranasal treatment for stress-induced affective disorders and PTSD. The global ...

  4. 4 hours ago · A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...

  5. 18 hours ago · SILO. 92.52%. SARASOTA, FL - Silo Pharma, Inc. (NASDAQ:SILO), a biopharmaceutical company, has announced an exclusive global license agreement to develop and possibly bring to market its Alzheimer ...

  6. 7 hours ago · Silo Pharma, Inc. announced that it has entered into an exclusive global license agreement to further develop, manufacture, and commercialize its Alzheimer's drug SPC-14.

  7. People also ask

  8. 3 hours ago · Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has entered into an exclusive global license agreement. The agreement outlines the company’s intentions to further develop, manufacture and ...

  1. People also search for